Cold Plasma Market by Application (Plasma Sterilization, Wastewater Treatment, Wound Healing, Surface Treatment, Coating, Packaging, Thin Film Deposition, Etching, Printing, Skin Treatment), by Regime (Low Pressure, Atmospheric) - Global Forecast to 2031
The global cold plasma market is projected to reach USD 3.03 billion by 2031 from USD 2.15 billion in 2026, at a CAGR of 7.1 % during the forecast period.
The growing need for effective, low-temperature sterilization and surface modification of medical devices is driving the adoption of cold plasma technology. Cold plasma enables non-thermal treatment of heat-sensitive medical devices while reducing reliance on harsh chemicals and minimizing material damage. Increasing demand for sterile medical equipment, infection control, and advanced surface treatment, particularly for catheters, implants, surgical instruments, and other polymer-based devices, is expected to support market growth. Furthermore, rising healthcare expenditure, stringent sterilization requirements, and advancements in plasma-based medical technologies are likely to drive further adoption of cold plasma solutions.
The non-thermal, environmentally friendly nature of cold plasma, along with its ability to reduce reliance on chemical treatments, is driving its adoption across industries. Moreover, advancements in plasma technology, development of application-specific systems, and increasing demand for efficient and customizable surface treatment solutions are expected to further accelerate segment growth.
The regional market is further supported by advanced manufacturing capabilities, stringent environmental regulations, growing demand for sustainable and chemical-free processing, and increasing investments in healthcare technologies. Moreover, the rising adoption of cold plasma for medical device sterilization, wound care, infection control, and industrial surface treatment, along with ongoing technological advancements and R&D activities, is expected to further drive market growth in Europe.
A breakdown of the primary participants referred to for this report is provided below:
The growing need for effective, low-temperature sterilization and surface modification of medical devices is driving the adoption of cold plasma technology. Cold plasma enables non-thermal treatment of heat-sensitive medical devices while reducing reliance on harsh chemicals and minimizing material damage. Increasing demand for sterile medical equipment, infection control, and advanced surface treatment, particularly for catheters, implants, surgical instruments, and other polymer-based devices, is expected to support market growth. Furthermore, rising healthcare expenditure, stringent sterilization requirements, and advancements in plasma-based medical technologies are likely to drive further adoption of cold plasma solutions.
“Based on industry, the medical industry segment of the cold plasma market is expected to register the highest share during the forecast period.”
The growing adoption of plasma-based solutions for wound healing, sterilization, disinfection, and surgical applications mainly drives the demand for cold plasma technology in the medical industry. The increasing prevalence of chronic wounds, rising demand for minimally invasive procedures, and growing emphasis on infection prevention are supporting the adoption of cold plasma systems across hospitals, clinics, and medical-device manufacturing facilities. Moreover, the focus on non-thermal sterilization, antimicrobial treatment, reduced chemical usage, patient safety, and environmentally friendly healthcare processes is encouraging the adoption of cold plasma technologies. Technological advancements in atmospheric-pressure plasma jets, plasma-based wound-care devices, and plasma sterilization systems are further expanding the scope of cold plasma applications, supporting the medical industry segment in registering the highest share during the forecast period.“By application, the surface treatment & activation segment is expected to capture the highest CAGR of the cold plasma market.”
Based on application, the surface treatment & activation segment is anticipated to register the highest CAGR during the forecast period. This growth can be attributed to the increasing use of cold plasma to enhance surface adhesion, wettability, printability, and bonding properties across polymer & plastics, textiles, electronics, and automotive applications.The non-thermal, environmentally friendly nature of cold plasma, along with its ability to reduce reliance on chemical treatments, is driving its adoption across industries. Moreover, advancements in plasma technology, development of application-specific systems, and increasing demand for efficient and customizable surface treatment solutions are expected to further accelerate segment growth.
“By regime, the low-pressure cold plasma segment is expected to register the highest CAGR in the cold plasma market.”
The low-pressure cold plasma segment is projected to record the highest CAGR, primarily due to its increasing use in high-precision manufacturing processes, particularly in semiconductor fabrication, electronics component processing, and specialized medical applications. The segment benefits from the ability to operate under controlled vacuum conditions, enabling precise plasma density, treatment uniformity, and repeatable process outcomes. Rising investments in advanced manufacturing facilities and the increasing integration of plasma-based processes into automated production lines are expected to further accelerate the adoption of low-pressure systems.“Europe accounted for the largest share of the cold plasma market by region.”
The global cold plasma market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is expected to account for a significant share of the global cold plasma market, supported by the increasing adoption of cold plasma technologies across medical, polymer & plastic, textile, and electronics industries, as well as the strong presence of key market players in the region.The regional market is further supported by advanced manufacturing capabilities, stringent environmental regulations, growing demand for sustainable and chemical-free processing, and increasing investments in healthcare technologies. Moreover, the rising adoption of cold plasma for medical device sterilization, wound care, infection control, and industrial surface treatment, along with ongoing technological advancements and R&D activities, is expected to further drive market growth in Europe.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (45%), Tier 2 (25%), and Tier 3 (30%)
- By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- By Region: North America (35%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (5%)
Research Coverage
This report studies the cold plasma market by industry, application, regime, and region. The report also examines factors such as drivers, restraints, opportunities, and challenges affecting market growth and provides details on the competitive landscape among market leaders. Furthermore, the report analyzes micromarkets by their individual growth trends and forecasts revenue for market segments across five major regions (and the countries within these regions).Reasons to Buy the Report
The report will enable established firms, as well as entrants/smaller firms, to gauge the pulse of the market, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.This report provides insights on the following pointers
- Analysis of key drivers (increased benefits and wider application, rising use in wound healing, growing applications in cancer and infectious disease, technological advancements, and rising demand for non-thermal sterilization and surface treatment), restraints (high capital investments and limited plasma penetration and non-uniform treatment), opportunities (sustainable and chemical-reduced processing and emerging countries offering opportunities), and challenges (limited commercialization and awareness and management of reactive species and process conditions)
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global cold plasma market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global cold plasma market
- Market Development: Comprehensive information on the lucrative emerging markets by industry, application, and regime.
- Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global cold plasma market.
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global cold plasma market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN COLD PLASMA MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 COLD PLASMA MARKET OVERVIEW
3.2 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY AND END USER
3.3 GEOGRAPHIC SNAPSHOT OF COLD PLASMA MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Growing preference for low-temperature and chemical-reduced processing to drive cold plasma adoption
4.2.1.2 Rising use of cold plasma in wound healing
4.2.1.3 Emerging applications in oncology and infectious diseases
4.2.1.4 Technological advancements and product innovation
4.2.1.5 Rising demand for non-thermal sterilization and surface treatment for medical devices
4.2.2 RESTRAINTS
4.2.2.1 High initial investments
4.2.2.2 Limited plasma penetration and non-uniform treatment
4.2.3 OPPORTUNITIES
4.2.3.1 Growing focus on sustainable and chemical-reduced processing
4.2.3.2 Favorable prospects in emerging economies
4.2.4 CHALLENGES
4.2.4.1 Limited commercialization and awareness
4.2.4.2 Management of reactive species and process conditions during cold plasma operations
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN COLD PLASMA MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRIES
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND, BY REGIME (2023–2025)
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025)
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 901890)
5.7.2 EXPORT SCENARIO (HS CODE 901890)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: COLD ATMOSPHERIC ARGON PLASMA FOR CHRONIC WOUND TREATMENT
5.11.2 CASE STUDY 2: PLASMA SURFACE ACTIVATION OF PEEK FOR MEDICAL DEVICES
5.11.3 CASE STUDY 3: PLASMA ACTIVATION FOR HIGH-QUALITY PAD PRINTING
5.12 IMPACT OF 2025 US TARIFFS—COLD PLASMA MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRIES/REGIONS
5.12.4.1 Canada
5.12.4.2 Asia Pacific
5.12.4.3 Europe
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 DIELECTRIC BARRIER DISCHARGE (DBD)
6.1.2 ATMOSPHERIC PRESSURE PLASMA JET (APPJ)
6.1.3 PLASMA-ACTIVATED WATER/LIQUID (PAW/PAL)
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 ULTRAVIOLET LIGHT
6.2.2 HYDROGEN PEROXIDE-BASED STERILIZATION
6.2.3 LASER TECHNOLOGY
6.3 ADJACENT TECHNOLOGIES
6.3.1 NANOTECHNOLOGY AND ANTIMICROBIAL COATINGS
6.3.2 ADVANCED SURFACE TREATMENT TECHNOLOGIES
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR-TERM (2025–2027) INCLUDES ALL INDUSTRIES
6.4.2 MID-TERM (2028–2030)
6.4.3 LONG-TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PLASMA-ASSISTED PHARMACEUTICAL AND DRUG DELIVERY APPLICATIONS
6.6.2 ADVANCED AGRICULTURAL AND PLANT-PRODUCTION APPLICATIONS
6.6.3 FOOD WASTE VALORIZATION AND VALUE-ADDED FOOD PROCESSING
6.6.4 ADVANCED CONTAMINANT REMEDIATION IN WATER AND WASTEWATER
6.6.5 PLASMA-FUNCTIONALIZED BIOMATERIALS AND ADVANCED THERAPEUTIC MATERIALS
6.7 IMPACT OF AI/GENERATIVE AI ON COLD PLASMA MARKET
6.7.1 TOP USE CASES AND MARKET POTENTIAL
6.7.2 BEST PRACTICES
6.7.3 CASE STUDIES OF AI IMPLEMENTATION
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN COLD PLASMA MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 NORTH AMERICA
7.1.2 EUROPE
7.1.3 ASIA PACIFIC
7.1.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.5 INDUSTRY STANDARDS
7.1.5.1 Medical Electrical Equipment Safety Standard – IEC 60601-1
7.1.5.2 Non-thermal Plasma Wound-treatment Equipment Standard – IEC 60601-2-91:2026
7.1.5.3 Quality Management System Standard For Medical Devices– ISO 13485:2016
7.1.5.4 Cold Atmospheric Pressure Plasma Characterization Specification – DIN SPEC 91315:2025-07
7.1.5.5 Environmental Management System Standard – ISO 14001:2026
7.1.5.6 Quality Management System Standard – ISO 9001:2015
7.2 SUSTAINABILITY INITIATIVES
7.2.1 SUSTAINABLE SURFACE TREATMENT THROUGH ATMOSPHERIC PLASMA – PLASMATREAT GMBH
7.2.2 REDUCING VOLATILE ORGANIC COMPOUND (VOCS) AND CHEMICAL USE THROUGH ATMOSPHERIC PLASMA – MYCRONIC
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.3.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.1.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS & BUYING CRITERIA
8.2.1 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 COLD PLASMA MARKET, BY INDUSTRY
9.1 INTRODUCTION
9.2 POLYMER & PLASTIC INDUSTRY
9.2.1 GROWING ADOPTION OF ECO-FRIENDLY SURFACE MODIFICATION TECHNOLOGIES
9.3 TEXTILE INDUSTRY
9.3.1 COLD PLASMA TECHNOLOGY OFFERS COST-SAVING AND ECO-FRIENDLY OPTIONS FOR TEXTILE PROCESSING
9.4 ELECTRONICS & SEMICONDUCTOR INDUSTRY
9.4.1 GROWING SEMICONDUCTOR INDUSTRY DEMANDS SUPPORT ADOPTION OF ADVANCED PLASMA PROCESSING TECHNOLOGIES
9.5 FOOD & AGRICULTURE INDUSTRY
9.5.1 GROWING ADOPTION OF NON-THERMAL TECHNOLOGIES FOR FOOD PROCESSING AND AGRICULTURAL APPLICATIONS
9.6 MEDICAL INDUSTRY
9.6.1 GROWING CLINICAL ADOPTION OF COLD PLASMA FOR WOUND HEALING AND ANTIMICROBIAL APPLICATIONS
9.7 COSMETICS INDUSTRY
9.7.1 EXPANDING APPLICATION OF COLD PLASMA IN DERMATOLOGICAL AND AESTHETIC TREATMENTS
9.8 PHARMACEUTICAL INDUSTRY
9.8.1 EXPANDING APPLICATION OF COLD PLASMA IN PHARMACEUTICAL STERILIZATION AND DRUG DELIVERY
9.9 OTHER INDUSTRIES
10 COLD PLASMA MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 SURFACE TREATMENT & ACTIVATION
10.2.1 INCREASING DEMAND FOR IMPROVED SURFACE ADHESION AND ACTIVATION IN POLYMER PROCESSING
10.3 COATING & THIN-FILM DEPOSITION
10.3.1 INCREASING APPLICATION OF COLD PLASMA FOR FUNCTIONAL AND PROTECTIVE SURFACE COATINGS
10.4 PRINTING
10.4.1 BETTER DYE UPTAKE & PRINTING PERFORMANCE AND REDUCED RELIANCE ON WATER/CHEMICAL PRETREATMENT DRIVES ADOPTION
10.5 STERILIZATION & DECONTAMINATION
10.5.1 INCREASING APPLICATION OF COLD PLASMA FOR STERILIZATION & DECONTAMINATION DRIVES MARKET
10.6 WOUND HEALING
10.6.1 RISING PREVALENCE OF CHRONIC WOUNDS SUPPORTS USAGE OF COLD PLASMA IN WOUND MANAGEMENT
10.7 SURFACE ETCHING
10.7.1 INCREASING REQUIREMENT FOR HIGH-PRECISION PLASMA ETCHING IN SEMICONDUCTOR MANUFACTURING
10.8 SURGICAL APPLICATIONS
10.8.1 EXPANDING APPLICATIONS OF COLD PLASMA IN SURGICAL PROCEDURES AND CANCER TREATMENT
10.9 AESTHETIC SKIN PROCEDURES
10.9.1 INCREASING DEMAND FOR NON-SURGICAL AESTHETIC PROCEDURES SUPPORTS COLD PLASMA APPLICATIONS
10.10 OTHER APPLICATIONS
11 COLD PLASMA MARKET, BY REGIME
11.1 INTRODUCTION
11.2 ATMOSPHERIC COLD PLASMA
11.2.1 INCREASING ADOPTION OF ATMOSPHERIC COLD PLASMA FOR SCALABLE AND EFFICIENT SURFACE TREATMENT
11.3 LOW-PRESSURE COLD PLASMA
11.3.1 HIGH TREATMENT EFFECTIVENESS SUPPORTS APPLICATIONS DESPITE VACUUM-SYSTEM LIMITATIONS
12 COLD PLASMA MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 Strong semiconductor investment, food-safety requirements, and medical applications support market growth
12.2.3 CANADA
12.2.3.1 Rising cancer cases & R&D to drive market growth in Canada
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Strong industrial base and demand for sustainable processing technologies propel adoption
12.3.3 FRANCE
12.3.3.1 Strong electronics and semiconductor investments support cold plasma market growth
12.3.4 UK
12.3.4.1 Investments in semiconductor and agricultural technologies support cold plasma adoption
12.3.5 ITALY
12.3.5.1 Aging population and healthcare investment support cold plasma market growth
12.3.6 SPAIN
12.3.6.1 Growing healthcare needs and cancer burden support cold plasma applications in Spain
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Strong textile, electronics, and food-processing industries support cold plasma adoption in China
12.4.3 JAPAN
12.4.3.1 Aging population, healthcare needs, and advanced manufacturing support cold plasma applications in Japan
12.4.4 INDIA
12.4.4.1 Growing R&D investment and textile exports support cold plasma adoption in India
12.4.5 AUSTRALIA
12.4.5.1 Growing healthcare needs and medical R&D support cold plasma adoption in Australia
12.4.6 SOUTH KOREA
12.4.6.1 Government support and advanced healthcare infrastructure support cold plasma adoption in South Korea
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Growing R&D investment and healthcare innovation support cold plasma adoption in Brazil
12.5.3 MEXICO
12.5.3.1 Growing healthcare needs support cold plasma adoption in Mexico
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Kingdom of Saudi Arabia
12.6.2.1.1 Healthcare modernization and technology development drive cold plasma adoption in Saudi Arabia
12.6.2.2 UAE
12.6.2.2.1 Healthcare innovation and advanced technology development support cold plasma adoption in the UAE
12.6.2.3 Rest of GCC Countries
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLD PLASMA MARKET
13.3 REVENUE ANALYSIS, 2023–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.4.1 GLOBAL SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.4.2 US MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.4.3 EUROPE MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Industry footprint
13.5.5.4 Application footprint
13.5.5.5 Regime footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 NORDSON CORPORATION
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.3.2 Expansions
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD.
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.3.4 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 JUDGES SCIENTIFIC PLC
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & updates
14.1.3.3.2 Deals
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 PVA TEPLA AG
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses and competitive threats
14.1.5 BODYCOTE
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Other developments
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 APYX MEDICAL CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches & approvals
14.1.6.3.2 Other developments
14.1.7 VIROMED MEDICAL AG
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product approvals
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 SAMCO INC.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.9 MYCRONIC
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Other developments
14.1.10 PLASMATREAT GMBH
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.10.3.3 Expansions
14.1.10.3.4 Other developments
14.1.11 P2I LTD
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.11.3.2 Other developments
14.1.12 ENERCON INDUSTRIES CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.12.3.2 Expansions
14.1.13 TANTEC A/S
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Deals
14.1.14 ACXYS TECHNOLOGIES
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.15 KEYLINK
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Other developments
14.2 OTHER PLAYERS
14.2.1 DIENER ELECTRONIC GMBH & CO.KG
14.2.2 US MEDICAL INNOVATIONS
14.2.3 LEAFLIFE TECHNOLOGY
14.2.4 SOFTAL CORONA & PLASMA GMBH
14.2.5 FERRARINI & BENELLI SRL
14.2.6 NEOPLAS MED GMBH
14.2.7 TERRAPLASMA GMBH
14.2.8 MOLECULAR PLASMA GROUP
14.2.9 CINOGY TECHNOLOGIES GMBH
14.2.10 PLASMALEX
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.1.2.3 Breakdown of primary interviews
15.1.2.4 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
15.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
15.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
15.2.4 TOP-DOWN APPROACH
15.2.5 BASE NUMBER CALCULATION
15.2.6 DEMAND-SIDE APPROACH
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
15.4 MARKET SHARE ASSESSMENT
15.5 RESEARCH ASSUMPTIONS
15.5.1 STUDY ASSUMPTIONS
15.5.2 GROWTH RATE ASSUMPTIONS
15.6 RISK ASSESSMENT
15.7 RESEARCH LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 GEOGRAPHIC ANALYSIS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN COLD PLASMA MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 COLD PLASMA MARKET OVERVIEW
3.2 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY AND END USER
3.3 GEOGRAPHIC SNAPSHOT OF COLD PLASMA MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Growing preference for low-temperature and chemical-reduced processing to drive cold plasma adoption
4.2.1.2 Rising use of cold plasma in wound healing
4.2.1.3 Emerging applications in oncology and infectious diseases
4.2.1.4 Technological advancements and product innovation
4.2.1.5 Rising demand for non-thermal sterilization and surface treatment for medical devices
4.2.2 RESTRAINTS
4.2.2.1 High initial investments
4.2.2.2 Limited plasma penetration and non-uniform treatment
4.2.3 OPPORTUNITIES
4.2.3.1 Growing focus on sustainable and chemical-reduced processing
4.2.3.2 Favorable prospects in emerging economies
4.2.4 CHALLENGES
4.2.4.1 Limited commercialization and awareness
4.2.4.2 Management of reactive species and process conditions during cold plasma operations
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN COLD PLASMA MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF BUYERS
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS & FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRIES
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023–2025)
5.6.2 AVERAGE SELLING PRICE TREND, BY REGIME (2023–2025)
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025)
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 901890)
5.7.2 EXPORT SCENARIO (HS CODE 901890)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: COLD ATMOSPHERIC ARGON PLASMA FOR CHRONIC WOUND TREATMENT
5.11.2 CASE STUDY 2: PLASMA SURFACE ACTIVATION OF PEEK FOR MEDICAL DEVICES
5.11.3 CASE STUDY 3: PLASMA ACTIVATION FOR HIGH-QUALITY PAD PRINTING
5.12 IMPACT OF 2025 US TARIFFS—COLD PLASMA MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRIES/REGIONS
5.12.4.1 Canada
5.12.4.2 Asia Pacific
5.12.4.3 Europe
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 DIELECTRIC BARRIER DISCHARGE (DBD)
6.1.2 ATMOSPHERIC PRESSURE PLASMA JET (APPJ)
6.1.3 PLASMA-ACTIVATED WATER/LIQUID (PAW/PAL)
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 ULTRAVIOLET LIGHT
6.2.2 HYDROGEN PEROXIDE-BASED STERILIZATION
6.2.3 LASER TECHNOLOGY
6.3 ADJACENT TECHNOLOGIES
6.3.1 NANOTECHNOLOGY AND ANTIMICROBIAL COATINGS
6.3.2 ADVANCED SURFACE TREATMENT TECHNOLOGIES
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR-TERM (2025–2027) INCLUDES ALL INDUSTRIES
6.4.2 MID-TERM (2028–2030)
6.4.3 LONG-TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PLASMA-ASSISTED PHARMACEUTICAL AND DRUG DELIVERY APPLICATIONS
6.6.2 ADVANCED AGRICULTURAL AND PLANT-PRODUCTION APPLICATIONS
6.6.3 FOOD WASTE VALORIZATION AND VALUE-ADDED FOOD PROCESSING
6.6.4 ADVANCED CONTAMINANT REMEDIATION IN WATER AND WASTEWATER
6.6.5 PLASMA-FUNCTIONALIZED BIOMATERIALS AND ADVANCED THERAPEUTIC MATERIALS
6.7 IMPACT OF AI/GENERATIVE AI ON COLD PLASMA MARKET
6.7.1 TOP USE CASES AND MARKET POTENTIAL
6.7.2 BEST PRACTICES
6.7.3 CASE STUDIES OF AI IMPLEMENTATION
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN COLD PLASMA MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS & COMPLIANCE
7.1.1 NORTH AMERICA
7.1.2 EUROPE
7.1.3 ASIA PACIFIC
7.1.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.5 INDUSTRY STANDARDS
7.1.5.1 Medical Electrical Equipment Safety Standard – IEC 60601-1
7.1.5.2 Non-thermal Plasma Wound-treatment Equipment Standard – IEC 60601-2-91:2026
7.1.5.3 Quality Management System Standard For Medical Devices– ISO 13485:2016
7.1.5.4 Cold Atmospheric Pressure Plasma Characterization Specification – DIN SPEC 91315:2025-07
7.1.5.5 Environmental Management System Standard – ISO 14001:2026
7.1.5.6 Quality Management System Standard – ISO 9001:2015
7.2 SUSTAINABILITY INITIATIVES
7.2.1 SUSTAINABLE SURFACE TREATMENT THROUGH ATMOSPHERIC PLASMA – PLASMATREAT GMBH
7.2.2 REDUCING VOLATILE ORGANIC COMPOUND (VOCS) AND CHEMICAL USE THROUGH ATMOSPHERIC PLASMA – MYCRONIC
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.3.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.1.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS & BUYING CRITERIA
8.2.1 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
9 COLD PLASMA MARKET, BY INDUSTRY
9.1 INTRODUCTION
9.2 POLYMER & PLASTIC INDUSTRY
9.2.1 GROWING ADOPTION OF ECO-FRIENDLY SURFACE MODIFICATION TECHNOLOGIES
9.3 TEXTILE INDUSTRY
9.3.1 COLD PLASMA TECHNOLOGY OFFERS COST-SAVING AND ECO-FRIENDLY OPTIONS FOR TEXTILE PROCESSING
9.4 ELECTRONICS & SEMICONDUCTOR INDUSTRY
9.4.1 GROWING SEMICONDUCTOR INDUSTRY DEMANDS SUPPORT ADOPTION OF ADVANCED PLASMA PROCESSING TECHNOLOGIES
9.5 FOOD & AGRICULTURE INDUSTRY
9.5.1 GROWING ADOPTION OF NON-THERMAL TECHNOLOGIES FOR FOOD PROCESSING AND AGRICULTURAL APPLICATIONS
9.6 MEDICAL INDUSTRY
9.6.1 GROWING CLINICAL ADOPTION OF COLD PLASMA FOR WOUND HEALING AND ANTIMICROBIAL APPLICATIONS
9.7 COSMETICS INDUSTRY
9.7.1 EXPANDING APPLICATION OF COLD PLASMA IN DERMATOLOGICAL AND AESTHETIC TREATMENTS
9.8 PHARMACEUTICAL INDUSTRY
9.8.1 EXPANDING APPLICATION OF COLD PLASMA IN PHARMACEUTICAL STERILIZATION AND DRUG DELIVERY
9.9 OTHER INDUSTRIES
10 COLD PLASMA MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 SURFACE TREATMENT & ACTIVATION
10.2.1 INCREASING DEMAND FOR IMPROVED SURFACE ADHESION AND ACTIVATION IN POLYMER PROCESSING
10.3 COATING & THIN-FILM DEPOSITION
10.3.1 INCREASING APPLICATION OF COLD PLASMA FOR FUNCTIONAL AND PROTECTIVE SURFACE COATINGS
10.4 PRINTING
10.4.1 BETTER DYE UPTAKE & PRINTING PERFORMANCE AND REDUCED RELIANCE ON WATER/CHEMICAL PRETREATMENT DRIVES ADOPTION
10.5 STERILIZATION & DECONTAMINATION
10.5.1 INCREASING APPLICATION OF COLD PLASMA FOR STERILIZATION & DECONTAMINATION DRIVES MARKET
10.6 WOUND HEALING
10.6.1 RISING PREVALENCE OF CHRONIC WOUNDS SUPPORTS USAGE OF COLD PLASMA IN WOUND MANAGEMENT
10.7 SURFACE ETCHING
10.7.1 INCREASING REQUIREMENT FOR HIGH-PRECISION PLASMA ETCHING IN SEMICONDUCTOR MANUFACTURING
10.8 SURGICAL APPLICATIONS
10.8.1 EXPANDING APPLICATIONS OF COLD PLASMA IN SURGICAL PROCEDURES AND CANCER TREATMENT
10.9 AESTHETIC SKIN PROCEDURES
10.9.1 INCREASING DEMAND FOR NON-SURGICAL AESTHETIC PROCEDURES SUPPORTS COLD PLASMA APPLICATIONS
10.10 OTHER APPLICATIONS
11 COLD PLASMA MARKET, BY REGIME
11.1 INTRODUCTION
11.2 ATMOSPHERIC COLD PLASMA
11.2.1 INCREASING ADOPTION OF ATMOSPHERIC COLD PLASMA FOR SCALABLE AND EFFICIENT SURFACE TREATMENT
11.3 LOW-PRESSURE COLD PLASMA
11.3.1 HIGH TREATMENT EFFECTIVENESS SUPPORTS APPLICATIONS DESPITE VACUUM-SYSTEM LIMITATIONS
12 COLD PLASMA MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 Strong semiconductor investment, food-safety requirements, and medical applications support market growth
12.2.3 CANADA
12.2.3.1 Rising cancer cases & R&D to drive market growth in Canada
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Strong industrial base and demand for sustainable processing technologies propel adoption
12.3.3 FRANCE
12.3.3.1 Strong electronics and semiconductor investments support cold plasma market growth
12.3.4 UK
12.3.4.1 Investments in semiconductor and agricultural technologies support cold plasma adoption
12.3.5 ITALY
12.3.5.1 Aging population and healthcare investment support cold plasma market growth
12.3.6 SPAIN
12.3.6.1 Growing healthcare needs and cancer burden support cold plasma applications in Spain
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Strong textile, electronics, and food-processing industries support cold plasma adoption in China
12.4.3 JAPAN
12.4.3.1 Aging population, healthcare needs, and advanced manufacturing support cold plasma applications in Japan
12.4.4 INDIA
12.4.4.1 Growing R&D investment and textile exports support cold plasma adoption in India
12.4.5 AUSTRALIA
12.4.5.1 Growing healthcare needs and medical R&D support cold plasma adoption in Australia
12.4.6 SOUTH KOREA
12.4.6.1 Government support and advanced healthcare infrastructure support cold plasma adoption in South Korea
12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Growing R&D investment and healthcare innovation support cold plasma adoption in Brazil
12.5.3 MEXICO
12.5.3.1 Growing healthcare needs support cold plasma adoption in Mexico
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Kingdom of Saudi Arabia
12.6.2.1.1 Healthcare modernization and technology development drive cold plasma adoption in Saudi Arabia
12.6.2.2 UAE
12.6.2.2.1 Healthcare innovation and advanced technology development support cold plasma adoption in the UAE
12.6.2.3 Rest of GCC Countries
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLD PLASMA MARKET
13.3 REVENUE ANALYSIS, 2023–2025
13.4 MARKET SHARE ANALYSIS, 2025
13.4.1 GLOBAL SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.4.2 US MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.4.3 EUROPE MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025)
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Industry footprint
13.5.5.4 Application footprint
13.5.5.5 Regime footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.7.1 FINANCIAL METRICS
13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & APPROVALS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 NORDSON CORPORATION
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.3.2 Expansions
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD.
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.3.4 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 JUDGES SCIENTIFIC PLC
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & updates
14.1.3.3.2 Deals
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 PVA TEPLA AG
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses and competitive threats
14.1.5 BODYCOTE
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Other developments
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 APYX MEDICAL CORPORATION
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Product launches & approvals
14.1.6.3.2 Other developments
14.1.7 VIROMED MEDICAL AG
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product approvals
14.1.7.3.2 Deals
14.1.7.3.3 Other developments
14.1.8 SAMCO INC.
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches
14.1.9 MYCRONIC
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Other developments
14.1.10 PLASMATREAT GMBH
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches
14.1.10.3.2 Deals
14.1.10.3.3 Expansions
14.1.10.3.4 Other developments
14.1.11 P2I LTD
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.11.3.2 Other developments
14.1.12 ENERCON INDUSTRIES CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.12.3.2 Expansions
14.1.13 TANTEC A/S
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.3 Recent developments
14.1.13.3.1 Product launches
14.1.13.3.2 Deals
14.1.14 ACXYS TECHNOLOGIES
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.15 KEYLINK
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Other developments
14.2 OTHER PLAYERS
14.2.1 DIENER ELECTRONIC GMBH & CO.KG
14.2.2 US MEDICAL INNOVATIONS
14.2.3 LEAFLIFE TECHNOLOGY
14.2.4 SOFTAL CORONA & PLASMA GMBH
14.2.5 FERRARINI & BENELLI SRL
14.2.6 NEOPLAS MED GMBH
14.2.7 TERRAPLASMA GMBH
14.2.8 MOLECULAR PLASMA GROUP
14.2.9 CINOGY TECHNOLOGIES GMBH
14.2.10 PLASMALEX
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.2 PRIMARY DATA
15.1.2.1 Key data from primary sources
15.1.2.2 Key industry insights
15.1.2.3 Breakdown of primary interviews
15.1.2.4 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
15.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
15.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
15.2.4 TOP-DOWN APPROACH
15.2.5 BASE NUMBER CALCULATION
15.2.6 DEMAND-SIDE APPROACH
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
15.4 MARKET SHARE ASSESSMENT
15.5 RESEARCH ASSUMPTIONS
15.5.1 STUDY ASSUMPTIONS
15.5.2 GROWTH RATE ASSUMPTIONS
15.6 RISK ASSESSMENT
15.7 RESEARCH LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 GEOGRAPHIC ANALYSIS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 COLD PLASMA MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 WHITE SPACE OPPORTUNITIES IN COLD PLASMA MARKET
TABLE 4 INTERCONNECTED MARKETS IN COLD PLASMA MARKET
TABLE 5 CROSS-SECTOR OPPORTUNITIES IN COLD PLASMA MARKET
TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN COLD PLASMA MARKET
TABLE 7 COLD PLASMA MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION)
TABLE 9 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION (2023?2025) (USD)
TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS)
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS)
TABLE 13 COLD PLASMA MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES,2025
TABLE 15 COLD PLASMA MARKET: MAJOR PATENTS
TABLE 16 KEY COMPANIES IMPLEMENTING AI IN COLD PLASMA MARKET
TABLE 17 BEST PRACTICES IN COLD PLASMA MARKET
TABLE 18 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE COLD PLASMA MARKET
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
TABLE 25 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
TABLE 26 ADOPTION BARRIERS AND INTERNAL CHALLENGES IN THE COLD PLASMA MARKET
TABLE 27 UNMET NEEDS IN COLD PLASMA MARKET FROM VARIOUS END USERS
TABLE 28 COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 29 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE POLYMER & PLASTIC INDUSTRY
TABLE 31 COLD PLASMA MARKET FOR THE POLYMER & PLASTIC INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 COMPARISON BETWEEN PLASMA TREATMENT AND TRADITIONAL TEXTILE PROCESSING
TABLE 33 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE TEXTILE INDUSTRY
TABLE 34 COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE ELECTRONICS & SEMICONDUCTOR INDUSTRY
TABLE 36 COLD PLASMA MARKET FOR ELECTRONICS & SEMICONDUCTOR INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE FOOD & AGRICULTURE INDUSTRY
TABLE 38 COLD PLASMA MARKET FOR THE FOOD & AGRICULTURE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE MEDICAL INDUSTRY
TABLE 40 COLD PLASMA MARKET FOR THE MEDICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE COSMETICS INDUSTRY
TABLE 42 COLD PLASMA MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 KEY PLAYERS PROVIDING PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY
TABLE 44 COLD PLASMA MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR OTHER INDUSTRIES
TABLE 46 COLD PLASMA MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 48 COLD PLASMA MARKET FOR APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 COLD PLASMA MARKET FOR SURFACE TREATMENT & ACTIVATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 COLD PLASMA MARKET FOR COATING & THIN-FILM DEPOSITION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 COLD PLASMA MARKET FOR PRINTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 COLD PLASMA MARKET FOR STERILIZATION & DECONTAMINATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 COLD PLASMA MARKET FOR WOUND HEALING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 COLD PLASMA MARKET FOR SURFACE ETCHING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 COLD PLASMA MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 COLD PLASMA MARKET FOR AESTHETIC SKIN PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 COLD PLASMA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 59 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ATMOSPHERIC COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
TABLE 61 ATMOSPHERIC COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 LOW PRESSURE COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
TABLE 63 LOW-PRESSURE COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 65 NORTH AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 67 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 68 NORTH AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 70 US: MACROECONOMIC INDICATORS
TABLE 71 US: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 72 US: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 73 US: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 74 CANADA: MACROECONOMIC INDICATORS
TABLE 75 CANADA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 76 CANADA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 77 CANADA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 78 EUROPE: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 80 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 81 EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 82 EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 83 GERMANY: MACROECONOMIC INDICATORS
TABLE 84 GERMANY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 85 GERMANY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 86 GERMANY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 87 FRANCE: MACROECONOMIC INDICATORS
TABLE 88 FRANCE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 89 FRANCE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 90 FRANCE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 91 UK: MACROECONOMIC INDICATORS
TABLE 92 UK: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 93 UK: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 94 UK: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 95 ITALY: MACROECONOMIC INDICATORS
TABLE 96 ITALY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 97 ITALY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 98 ITALY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 99 SPAIN: MACROECONOMIC INDICATORS
TABLE 100 SPAIN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 101 SPAIN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 102 SPAIN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 103 REST OF EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 104 REST OF EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 105 REST OF EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 106 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 109 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 111 CHINA: MACROECONOMIC INDICATORS
TABLE 112 CHINA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 113 CHINA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 114 CHINA: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 115 JAPAN: MACROECONOMIC INDICATORS
TABLE 116 JAPAN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 117 JAPAN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 118 JAPAN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 119 INDIA: MACROECONOMIC INDICATORS
TABLE 120 INDIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 121 INDIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 122 INDIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 123 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 124 AUSTRALIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 125 AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 126 AUSTRALIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 128 SOUTH KOREA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 129 SOUTH KOREA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 130 SOUTH KOREA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 131 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 132 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 134 LATIN AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 136 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 137 LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 138 LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 139 BRAZIL: MACROECONOMIC INDICATORS
TABLE 140 BRAZIL: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 141 BRAZIL: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 142 BRAZIL: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 143 MEXICO: MACROECONOMIC INDICATORS
TABLE 144 MEXICO: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 145 MEXICO: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 146 MEXICO: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 147 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 153 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 155 GCC COUNTRIES: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 157 GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 158 GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 159 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS
TABLE 160 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 161 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 162 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163 UAE: MACROECONOMIC INDICATORS
TABLE 164 UAE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 165 UAE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 166 UAE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 167 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 168 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 169 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 170 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 171 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 172 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 173 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2023–JULY 2026
TABLE 174 COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 175 US COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 176 EUROPE COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 177 COLD PLASMA MARKET: REGION FOOTPRINT
TABLE 178 COLD PLASMA MARKET: INDUSTRY FOOTPRINT
TABLE 179 COLD PLASMA MARKET: APPLICATION FOOTPRINT
TABLE 180 COLD PLASMA MARKET: REGIME FOOTPRINT
TABLE 181 COLD PLASMA MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 182 COLD PLASMA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
TABLE 183 COLD PLASMA MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 184 COLD PLASMA MARKET: DEALS, JANUARY 2023–JULY 2026
TABLE 185 COLD PLASMA MARKET: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 186 COLD PLASMA MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 187 NORDSON CORPORATION: COMPANY OVERVIEW
TABLE 188 NORDSON CORPORATION: PRODUCTS OFFERED
TABLE 189 NORDSON CORPORATION: DEALS, JANUARY 2023–JULY 2026
TABLE 190 NORDSON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 191 NORDSON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 192 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 193 ADTEC PLASMA TECHNOLOGY CO., LTD: PRODUCTS OFFERED
TABLE 194 ADTEC PLASMA TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 195 ADTEC PLASMA TECHNOLOGY CO., LTD.: DEALS, JANUARY 2023–JULY 2026
TABLE 196 ADTEC PLASMA TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 197 ADTEC PLASMA TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 198 JUDGES SCIENTIFIC PLC: COMPANY OVERVIEW
TABLE 199 JUDGES SCIENTIFIC PLC: PRODUCTS OFFERED
TABLE 200 JUDGES SCIENTIFIC PLC: PRODUCT LAUNCHES & UPDATES, JANUARY 2023–JULY 2026
TABLE 201 JUDGES SCIENTIFIC PLC: DEALS, JANUARY 2023- JULY 2026
TABLE 202 PVA TEPLA AG: COMPANY OVERVIEW
TABLE 203 PVA TEPLA AG: PRODUCTS OFFERED
TABLE 204 BODYCOTE.: COMPANY OVERVIEW
TABLE 205 BODYCOTE: PRODUCTS OFFERED
TABLE 206 BODYCOTE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 207 APYX MEDICAL CORPORATION: COMPANY OVERVIEW
TABLE 208 APYX MEDICAL CORPORATION: PRODUCTS OFFERED
TABLE 209 APYX MEDICAL CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 210 APYX MEDICAL CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 211 VIROMED MEDICAL AG: COMPANY OVERVIEW
TABLE 212 VIROMED MEDICAL AG: PRODUCTS OFFERED
TABLE 213 VIROMED MEDICAL AG: PRODUCT APPROVALS, JANUARY 2023–JULY 2026
TABLE 214 VIROMED MEDICAL AG: DEALS, JANUARY 2023- JULY 2026
TABLE 215 VIROMED MEDICAL AG: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 216 SAMCO INC.: COMPANY OVERVIEW
TABLE 217 SAMCO INC.: PRODUCTS OFFERED
TABLE 218 SAMCO INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 219 MYCRONIC: COMPANY OVERVIEW
TABLE 220 MYCRONIC: PRODUCTS OFFERED
TABLE 221 MYCRONIC: DEALS, JANUARY 2023- JULY 2026
TABLE 222 MYCRONIC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 223 PLASMATREAT GMBH: COMPANY OVERVIEW
TABLE 224 PLASMATREAT GMBH: PRODUCTS OFFERED
TABLE 225 PLASMATREAT GMBH: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 226 PLASMATREAT GMBH: DEALS, JANUARY 2023- JULY 2026
TABLE 227 PLASMATREAT GMBH: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 228 PLASMATREAT GMBH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 229 P2I LTD: COMPANY OVERVIEW
TABLE 230 P2I LTD: PRODUCTS OFFERED
TABLE 231 P2I LTD: DEALS, JANUARY 2023- JULY 2026
TABLE 232 P2I LTD: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 233 ENERCON INDUSTRIES CORPORATION: COMPANY OVERVIEW
TABLE 234 ENERCON INDUSTRIES CORPORATION: PRODUCTS OFFERED
TABLE 235 ENERCON INDUSTRIES CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 236 ENERCON INDUSTRIES CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 237 TANTEC A/S: COMPANY OVERVIEW
TABLE 238 TANTEC A/S: PRODUCTS OFFERED
TABLE 239 TANTEC A/S: SERVICE LAUNCHES, JANUARY 2023- JULY 2026
TABLE 240 TANTEC A/S: DEALS, JANUARY 2023- JULY 2026
TABLE 241 ACXYS TECHNOLOGIES.: COMPANY OVERVIEW
TABLE 242 ACXYS TECHNOLOGIES: PRODUCTS OFFERED
TABLE 243 ACXYS TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2023- JULY 2026
TABLE 244 KEYLINK: COMPANY OVERVIEW
TABLE 245 KEYLINK: PRODUCTS OFFERED
TABLE 246 KEYLINK: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 247 STUDY ASSUMPTIONS
TABLE 248 COLD PLASMA MARKET: RISK ASSESSMENT ANALYSIS
TABLE 1 COLD PLASMA MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 WHITE SPACE OPPORTUNITIES IN COLD PLASMA MARKET
TABLE 4 INTERCONNECTED MARKETS IN COLD PLASMA MARKET
TABLE 5 CROSS-SECTOR OPPORTUNITIES IN COLD PLASMA MARKET
TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN COLD PLASMA MARKET
TABLE 7 COLD PLASMA MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION)
TABLE 9 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION (2023?2025) (USD)
TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS)
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2021–2025 (USD THOUSANDS)
TABLE 13 COLD PLASMA MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES,2025
TABLE 15 COLD PLASMA MARKET: MAJOR PATENTS
TABLE 16 KEY COMPANIES IMPLEMENTING AI IN COLD PLASMA MARKET
TABLE 17 BEST PRACTICES IN COLD PLASMA MARKET
TABLE 18 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE COLD PLASMA MARKET
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
TABLE 25 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
TABLE 26 ADOPTION BARRIERS AND INTERNAL CHALLENGES IN THE COLD PLASMA MARKET
TABLE 27 UNMET NEEDS IN COLD PLASMA MARKET FROM VARIOUS END USERS
TABLE 28 COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 29 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE POLYMER & PLASTIC INDUSTRY
TABLE 31 COLD PLASMA MARKET FOR THE POLYMER & PLASTIC INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 COMPARISON BETWEEN PLASMA TREATMENT AND TRADITIONAL TEXTILE PROCESSING
TABLE 33 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE TEXTILE INDUSTRY
TABLE 34 COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE ELECTRONICS & SEMICONDUCTOR INDUSTRY
TABLE 36 COLD PLASMA MARKET FOR ELECTRONICS & SEMICONDUCTOR INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE FOOD & AGRICULTURE INDUSTRY
TABLE 38 COLD PLASMA MARKET FOR THE FOOD & AGRICULTURE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE MEDICAL INDUSTRY
TABLE 40 COLD PLASMA MARKET FOR THE MEDICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE COSMETICS INDUSTRY
TABLE 42 COLD PLASMA MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 KEY PLAYERS PROVIDING PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY
TABLE 44 COLD PLASMA MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR OTHER INDUSTRIES
TABLE 46 COLD PLASMA MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 48 COLD PLASMA MARKET FOR APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 COLD PLASMA MARKET FOR SURFACE TREATMENT & ACTIVATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 COLD PLASMA MARKET FOR COATING & THIN-FILM DEPOSITION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 COLD PLASMA MARKET FOR PRINTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 COLD PLASMA MARKET FOR STERILIZATION & DECONTAMINATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 COLD PLASMA MARKET FOR WOUND HEALING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 COLD PLASMA MARKET FOR SURFACE ETCHING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 COLD PLASMA MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 COLD PLASMA MARKET FOR AESTHETIC SKIN PROCEDURES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 COLD PLASMA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 59 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 ATMOSPHERIC COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
TABLE 61 ATMOSPHERIC COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 LOW PRESSURE COLD PLASMA MARKET, BY REGION, BY VOLUME, 2024–2031 (MILLION UNITS)
TABLE 63 LOW-PRESSURE COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 65 NORTH AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 67 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 68 NORTH AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 70 US: MACROECONOMIC INDICATORS
TABLE 71 US: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 72 US: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 73 US: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 74 CANADA: MACROECONOMIC INDICATORS
TABLE 75 CANADA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 76 CANADA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 77 CANADA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 78 EUROPE: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 80 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 81 EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 82 EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 83 GERMANY: MACROECONOMIC INDICATORS
TABLE 84 GERMANY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 85 GERMANY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 86 GERMANY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 87 FRANCE: MACROECONOMIC INDICATORS
TABLE 88 FRANCE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 89 FRANCE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 90 FRANCE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 91 UK: MACROECONOMIC INDICATORS
TABLE 92 UK: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 93 UK: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 94 UK: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 95 ITALY: MACROECONOMIC INDICATORS
TABLE 96 ITALY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 97 ITALY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 98 ITALY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 99 SPAIN: MACROECONOMIC INDICATORS
TABLE 100 SPAIN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 101 SPAIN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 102 SPAIN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 103 REST OF EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 104 REST OF EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 105 REST OF EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 106 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 109 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 111 CHINA: MACROECONOMIC INDICATORS
TABLE 112 CHINA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 113 CHINA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 114 CHINA: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 115 JAPAN: MACROECONOMIC INDICATORS
TABLE 116 JAPAN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 117 JAPAN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 118 JAPAN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 119 INDIA: MACROECONOMIC INDICATORS
TABLE 120 INDIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 121 INDIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 122 INDIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 123 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 124 AUSTRALIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 125 AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 126 AUSTRALIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 128 SOUTH KOREA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 129 SOUTH KOREA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 130 SOUTH KOREA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 131 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 132 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 134 LATIN AMERICA: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 136 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 137 LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 138 LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 139 BRAZIL: MACROECONOMIC INDICATORS
TABLE 140 BRAZIL: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 141 BRAZIL: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 142 BRAZIL: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 143 MEXICO: MACROECONOMIC INDICATORS
TABLE 144 MEXICO: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 145 MEXICO: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 146 MEXICO: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 147 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 152 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS)
TABLE 153 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 154 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 155 GCC COUNTRIES: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 157 GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 158 GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 159 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS
TABLE 160 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 161 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 162 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163 UAE: MACROECONOMIC INDICATORS
TABLE 164 UAE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 165 UAE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 166 UAE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 167 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 168 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 169 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 170 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION)
TABLE 171 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION)
TABLE 172 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 173 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2023–JULY 2026
TABLE 174 COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 175 US COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 176 EUROPE COLD PLASMA MARKET: DEGREE OF COMPETITION
TABLE 177 COLD PLASMA MARKET: REGION FOOTPRINT
TABLE 178 COLD PLASMA MARKET: INDUSTRY FOOTPRINT
TABLE 179 COLD PLASMA MARKET: APPLICATION FOOTPRINT
TABLE 180 COLD PLASMA MARKET: REGIME FOOTPRINT
TABLE 181 COLD PLASMA MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 182 COLD PLASMA MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
TABLE 183 COLD PLASMA MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 184 COLD PLASMA MARKET: DEALS, JANUARY 2023–JULY 2026
TABLE 185 COLD PLASMA MARKET: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 186 COLD PLASMA MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 187 NORDSON CORPORATION: COMPANY OVERVIEW
TABLE 188 NORDSON CORPORATION: PRODUCTS OFFERED
TABLE 189 NORDSON CORPORATION: DEALS, JANUARY 2023–JULY 2026
TABLE 190 NORDSON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 191 NORDSON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 192 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 193 ADTEC PLASMA TECHNOLOGY CO., LTD: PRODUCTS OFFERED
TABLE 194 ADTEC PLASMA TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 195 ADTEC PLASMA TECHNOLOGY CO., LTD.: DEALS, JANUARY 2023–JULY 2026
TABLE 196 ADTEC PLASMA TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 197 ADTEC PLASMA TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 198 JUDGES SCIENTIFIC PLC: COMPANY OVERVIEW
TABLE 199 JUDGES SCIENTIFIC PLC: PRODUCTS OFFERED
TABLE 200 JUDGES SCIENTIFIC PLC: PRODUCT LAUNCHES & UPDATES, JANUARY 2023–JULY 2026
TABLE 201 JUDGES SCIENTIFIC PLC: DEALS, JANUARY 2023- JULY 2026
TABLE 202 PVA TEPLA AG: COMPANY OVERVIEW
TABLE 203 PVA TEPLA AG: PRODUCTS OFFERED
TABLE 204 BODYCOTE.: COMPANY OVERVIEW
TABLE 205 BODYCOTE: PRODUCTS OFFERED
TABLE 206 BODYCOTE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 207 APYX MEDICAL CORPORATION: COMPANY OVERVIEW
TABLE 208 APYX MEDICAL CORPORATION: PRODUCTS OFFERED
TABLE 209 APYX MEDICAL CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JULY 2026
TABLE 210 APYX MEDICAL CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 211 VIROMED MEDICAL AG: COMPANY OVERVIEW
TABLE 212 VIROMED MEDICAL AG: PRODUCTS OFFERED
TABLE 213 VIROMED MEDICAL AG: PRODUCT APPROVALS, JANUARY 2023–JULY 2026
TABLE 214 VIROMED MEDICAL AG: DEALS, JANUARY 2023- JULY 2026
TABLE 215 VIROMED MEDICAL AG: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 216 SAMCO INC.: COMPANY OVERVIEW
TABLE 217 SAMCO INC.: PRODUCTS OFFERED
TABLE 218 SAMCO INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 219 MYCRONIC: COMPANY OVERVIEW
TABLE 220 MYCRONIC: PRODUCTS OFFERED
TABLE 221 MYCRONIC: DEALS, JANUARY 2023- JULY 2026
TABLE 222 MYCRONIC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 223 PLASMATREAT GMBH: COMPANY OVERVIEW
TABLE 224 PLASMATREAT GMBH: PRODUCTS OFFERED
TABLE 225 PLASMATREAT GMBH: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026
TABLE 226 PLASMATREAT GMBH: DEALS, JANUARY 2023- JULY 2026
TABLE 227 PLASMATREAT GMBH: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 228 PLASMATREAT GMBH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 229 P2I LTD: COMPANY OVERVIEW
TABLE 230 P2I LTD: PRODUCTS OFFERED
TABLE 231 P2I LTD: DEALS, JANUARY 2023- JULY 2026
TABLE 232 P2I LTD: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 233 ENERCON INDUSTRIES CORPORATION: COMPANY OVERVIEW
TABLE 234 ENERCON INDUSTRIES CORPORATION: PRODUCTS OFFERED
TABLE 235 ENERCON INDUSTRIES CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 236 ENERCON INDUSTRIES CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 237 TANTEC A/S: COMPANY OVERVIEW
TABLE 238 TANTEC A/S: PRODUCTS OFFERED
TABLE 239 TANTEC A/S: SERVICE LAUNCHES, JANUARY 2023- JULY 2026
TABLE 240 TANTEC A/S: DEALS, JANUARY 2023- JULY 2026
TABLE 241 ACXYS TECHNOLOGIES.: COMPANY OVERVIEW
TABLE 242 ACXYS TECHNOLOGIES: PRODUCTS OFFERED
TABLE 243 ACXYS TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2023- JULY 2026
TABLE 244 KEYLINK: COMPANY OVERVIEW
TABLE 245 KEYLINK: PRODUCTS OFFERED
TABLE 246 KEYLINK: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 247 STUDY ASSUMPTIONS
TABLE 248 COLD PLASMA MARKET: RISK ASSESSMENT ANALYSIS
LIST OF FIGURES
FIGURE 1 MARKET SCENARIO
FIGURE 2 GLOBAL COLD PLASMA MARKET, 2024–2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS COLD PLASMA MARKET, 2024–2026
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF COLD PLASMA MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS IN COLD PLASMA MARKET, 2026–2031
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COLD PLASMA MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 7 INCREASING USE OF COLD PLASMA FOR STERILIZATION, SURFACE TREATMENT, AND DECONTAMINATION TO DRIVE MARKET GROWTH
FIGURE 8 POLYMER & PLASTICS INDUSTRY ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 9 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 10 COLD PLASMA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 12 SUPPLY CHAIN ANALYSIS
FIGURE 13 COLD PLASMA PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 COLD PLASMA MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY REGIME, 2023–2025 (USD)
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN COLD PLASMA MARKET
FIGURE 17 INVESTMENT & FUNDING SCENARIO (2023–2026)
FIGURE 18 COLD PLASMA MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016–JULY 2026)
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR COLD PLASMA GENERATORS (JANUARY 2016–JULY 2026)
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN COLD PLASMA MARKET
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
FIGURE 22 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
FIGURE 23 NORTH AMERICA: COLD PLASMA MARKET SNAPSHOT (2025)
FIGURE 24 ASIA PACIFIC: COLD PLASMA MARKET SNAPSHOT (2025)
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN COLD PLASMA MARKET, 2023–2025
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 28 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 29 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 COLD PLASMA MARKET: COMPANY FOOTPRINT
FIGURE 31 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR COLD PLASMA MARKET
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR COLD PLASMA MARKET
FIGURE 34 COLD PLASMA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35 NORDSON CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 36 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 JUDGES SCIENTIFIC PLC: COMPANY SNAPSHOT (2025)
FIGURE 38 PVA TEPLA AG: COMPANY SNAPSHOT (2025)
FIGURE 39 BODYCOTE: COMPANY SNAPSHOT (2025)
FIGURE 40 APYX MEDICAL CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41 VIROMED MEDICAL AG: COMPANY SNAPSHOT (2025)
FIGURE 42 SAMCO INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 MYCRONIC: COMPANY SNAPSHOT (2025)
FIGURE 44 COLD PLASMA MARKET: RESEARCH DESIGN
FIGURE 45 PRIMARY SOURCES
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: NORDSON CORPORATION (2025)
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 SUPPLY-SIDE ANALYSIS: COLD PLASMA MARKET (2025)
FIGURE 55 DEMAND-SIDE APPROACH
FIGURE 56 COLD PLASMA MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 1 MARKET SCENARIO
FIGURE 2 GLOBAL COLD PLASMA MARKET, 2024–2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS COLD PLASMA MARKET, 2024–2026
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF COLD PLASMA MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS IN COLD PLASMA MARKET, 2026–2031
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COLD PLASMA MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 7 INCREASING USE OF COLD PLASMA FOR STERILIZATION, SURFACE TREATMENT, AND DECONTAMINATION TO DRIVE MARKET GROWTH
FIGURE 8 POLYMER & PLASTICS INDUSTRY ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 9 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 10 COLD PLASMA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 12 SUPPLY CHAIN ANALYSIS
FIGURE 13 COLD PLASMA PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 COLD PLASMA MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY REGIME, 2023–2025 (USD)
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN COLD PLASMA MARKET
FIGURE 17 INVESTMENT & FUNDING SCENARIO (2023–2026)
FIGURE 18 COLD PLASMA MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016–JULY 2026)
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR COLD PLASMA GENERATORS (JANUARY 2016–JULY 2026)
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN COLD PLASMA MARKET
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY
FIGURE 22 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY
FIGURE 23 NORTH AMERICA: COLD PLASMA MARKET SNAPSHOT (2025)
FIGURE 24 ASIA PACIFIC: COLD PLASMA MARKET SNAPSHOT (2025)
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN COLD PLASMA MARKET, 2023–2025
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 28 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 29 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30 COLD PLASMA MARKET: COMPANY FOOTPRINT
FIGURE 31 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR COLD PLASMA MARKET
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR COLD PLASMA MARKET
FIGURE 34 COLD PLASMA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35 NORDSON CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 36 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 JUDGES SCIENTIFIC PLC: COMPANY SNAPSHOT (2025)
FIGURE 38 PVA TEPLA AG: COMPANY SNAPSHOT (2025)
FIGURE 39 BODYCOTE: COMPANY SNAPSHOT (2025)
FIGURE 40 APYX MEDICAL CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41 VIROMED MEDICAL AG: COMPANY SNAPSHOT (2025)
FIGURE 42 SAMCO INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 MYCRONIC: COMPANY SNAPSHOT (2025)
FIGURE 44 COLD PLASMA MARKET: RESEARCH DESIGN
FIGURE 45 PRIMARY SOURCES
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: NORDSON CORPORATION (2025)
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 SUPPLY-SIDE ANALYSIS: COLD PLASMA MARKET (2025)
FIGURE 55 DEMAND-SIDE APPROACH
FIGURE 56 COLD PLASMA MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY
